Deutsche Apotheker Zeitung

What Deutsche Apotheker Zeitung does

Deutsche Apotheker Zeitung (DAZ) is the leading German-language trade publication serving the pharmacy professional community, published by Deutscher Apotheker Verlag (DAV-Medien) from Stuttgart, Germany. The publication operates as a digital-first editorial platform covering pharmacy policy, health economics, pharmaceutical science, pharmacy practice, and German pharmacy law for licensed pharmacists (Apotheker*innen), pharmacy owners, and pharmacy support staff (PTAs). Editorial scope is anchored around the German regulatory environment — most prominently the July 2026 Apothekenversorgung-Weiterentwicklungsgesetz (ApoVWG) reforms, Packungsfixum adjustments, Nullretax rules, and pharmacist scope-of-practice expansion. Content is organized across politics, economics, pharmacy science, practice, law, and continuing education sections, with BAK-certified continuing education (e.g., DAV-Rezeptursommer 2026) and recurring webinar series ("Medikation unter der Lupe" with 36+ episodes).

The underlying technology stack is a conventional multi-channel digital publishing platform: a website at deutsche-apotheker-zeitung.de, dedicated iOS and Android mobile applications, an ePaper archive, an email newsletter, an RSS feed, social media presence on Facebook, Instagram, and LinkedIn, and a branded podcast distributed via SoundCloud. Job postings are served through an embedded Jobpharm job board, and the platform gates premium content behind subscription paywalls. The business model rests on three revenue streams: recurring subscription revenue (Standard Abo and the DAZ Pur Abo digital-only tier), advertising and sponsored content (visible "Pressemeldung gesponsert von" placements on the homepage), and fee-based continuing education programs.

Distribution is exclusively direct-to-consumer via the DAZ website within Germany, with no intermediary resellers. Customer concentration sits in two primary segments — individual licensed pharmacists and pharmacy staff — supported by advertising-side demand from pharmaceutical industry and healthcare stakeholders. Institutional credibility is reinforced through close ties with the Bundesapothekerkammer (BAK), Deutscher Apothekerverband (DAV), and ABDA, the umbrella organization of German pharmacist associations. The publication is privately held, with no disclosed parent company, external investors, or funding rounds, and operates with 51-100 employees.

Name

Deutsche Apotheker Zeitung

Legal name

Deutscher Apotheker Verlag

Website

https://www.deutsche-apotheker-zeitung.de

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Deutsche Apotheker Zeitung is the leading German trade publication for pharmacists, published by Deutscher Apotheker Verlag from Stuttgart. It delivers a digital-first platform combining professional news, legal analysis, BAK-certified continuing education, and a podcast, serving licensed pharmacists, pharmacy owners, and PTAs across Germany.

Ownership category

akta.pro rank

Headquarters

HQ city

Stuttgart

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Print and Digital Subscriptions (Abo): DAZ offers subscription products including 'Abo*nnement*', 'DAZ Pur Abo', and ePaper access, generating recurring subscription revenue from pharmacists and pharmacy professionals.
2. Sponsored Content and Press Releases: The publication publishes sponsored press releases (e.g., 'Pressemeldung gesponsert von' sponsored content block) and boosted content redirects, generating advertising and sponsorship revenue.
3. Online Fortbildungen (Training Courses): Digital continuing education series such as the DAV-Rezeptursommer (with BAK-certified online lectures) are offered, generating revenue from professional development content for pharmacists.

Pricing tiers

Distribution channels1 record

Marketing channels8 records

Core offering

Deutsche Apotheker Zeitung (DAZ) is a subscription-based German trade publication for pharmacists, delivered through a website, mobile apps, ePaper, and podcast. It publishes daily news, regulatory analysis, and practice guidance on German pharmaceutical law, health policy, and pharmacy economics, and offers BAK-certified online continuing education such as the DAV-Rezeptursommer, gated behind individual subscriptions. The publication is operated by Deutscher Apotheker Verlag (DAV-Medien) out of Stuttgart and monetizes via paid subscriptions, sponsored content, and training programs.

Product overview

Deutsche Apotheker Zeitung (DAZ) is a leading German trade publication for pharmacists offering a unified online news and education platform. The core offering is the DAZ Online Portal providing comprehensive coverage of pharmacy news across politics, economics, pharmaceutical science, pharmacy practice, law, and continuing education. This is complemented by the DAZ-Podcast for audio news consumption, subscription-based access to premium content and webinar recordings like 'Medikation unter der Lupe', and mobile apps for iOS and Android. The platform also delivers digital continuing education through programs like the Rezeptursommer 2026.

Differentiator

Problem solved

Functional benefit

Products and services

• Deutsche Apotheker Zeitung (DAZ) Online News Portal The DAZ.de online news portal is the flagship product of Deutsche Apotheker Zeitung, providing daily news, analysis, and expert commentary on German pharmacy, health policy, pharmaceutical science, pharmacy practice, and pharmacy law, organised across Politik, Wirtschaft, Pharmazie, Apothekenpraxis, Recht, Spektrum, Fortbildungen, and Service. It is targeted at licensed pharmacists, pharmacy owners, pharmacy staff, and other German healthcare stakeholders, and is the central editorial product of the publication.
• DAZ-Podcast DAZ-Podcast is an audio news product delivering news from the German pharmaceutical industry and pharmacy sector, distributed via SoundCloud and embedded on the DAZ website. It targets German pharmacists and pharmacy stakeholders who prefer audio consumption of professional news on the go.
• DAZ Online-Fortbildungen (Continuing Education, e.g. DAV-Rezeptursommer 2026) DAZ Online-Fortbildungen is the digital continuing-education product of Deutsche Apotheker Zeitung, offering BAK (Bundesapothekerkammer)-certified online lectures that allow German pharmacists and pharmacy staff to earn officially recognised CE credits. The 2026 series, the DAV-Rezeptursommer, delivers six BAK-certified lectures on compounding plus one bonus lecture through October 2026; past webinar series such as 'Medikation unter der Lupe' (36+ cases) is also available as on-demand CE content for subscribers.

Quantifiable outcome

• DAV-Rezeptursommer offers 6 BAK-certified online lectures plus 1 bonus lecture, available until October 15, 2026.
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Five partnerships are on record, tiered core, major and minor.

• Deutscher Apotheker Verlag (DAV-Medien)coreOthersDAZ is published by Deutscher Apotheker Verlag (DAV-Medien), a specialized healthcare and pharmacy publishing house based in Stuttgart. DAV-Medien also publishes related professional titles and organizes professional events, providing the institutional backbone for DAZ's distribution and brand authority.
• Bundesapothekerkammer (BAK)majorStrategic or Co-development PartnerThe Bundesapothekerkammer (Federal Chamber of Pharmacists) develops and certifies curricula for continuing education. DAZ's DAV-Rezeptursommer training series is 'BAK-zertifiziert' (BAK-certified), meaning pharmacists earn officially recognized CE credits. DAZ also covers BAK activities and leadership statements (e.g., BAK-Präsident Dr. Armin Hoffmann's remarks at Pharmacon).
• DAV (Deutscher Apothekerverband)majorStrategic or Co-development PartnerThe Deutscher Apothekerverband (DAV) is the political and economic representation of German pharmacists. DAZ covers DAV events (DAV-Wirtschaftsforum), publishes DAV press releases, and the DAV-Rezeptursommer digital training series carries the DAV brand. DAV chairman Hans-Peter Hubmann is a recurring subject in DAZ coverage.
• ABDA – Bundesvereinigung Deutscher ApothekerverbändemajorStrategic or Co-development PartnerABDA is the umbrella organization of German pharmacists. DAZ extensively covers ABDA campaigns (e.g., 'Apothekensterben stoppen' online petition, protest actions), ABDA economic reports, and statements from ABDA-Präsident Thomas Preis. ABDA and DAZ share the professional pharmacy community as their core audience.
• JobpharmminorChannel Partner/ Reseller/ DistributorJobpharm (d3vhxe59evtid0.cloudfront.net integration) is embedded on DAZ's website as a job board for pharmaceutical professionals. It serves as a co-branded recruitment channel targeting DAZ's pharmacy audience.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• PTAheute: German pharmacy publication targeted at PTA (pharmacy technician) staff, providing news, education and continuing content. Overlaps with DAZ's secondary audience of pharmacy staff and competes for German-pharmacy advertising and reading time.
• Apotheke Adhoc: Leading German pharmacy news portal covering Apothekenreform, health policy and pharmacy practice for German pharmacists. The most direct competitor to DAZ, targeting the same professional audience with a similar subscription/digital-news model.

Broad incumbents

• Ärzte Zeitung: Major German medical trade newspaper providing daily news for physicians, with a digital-first subscription and CME model analogous to DAZ's positioning for pharmacists. Useful comparable for German healthcare trade journalism.
• Springer Medizin: German-language medical news and CME portal operated by Springer Nature, serving physicians and healthcare professionals. Demonstrates the larger-scale digital publishing model for German healthcare professionals with broader content scope than DAZ.
• Deutsches Ärzteblatt: Official organ of the German medical profession, offering news, peer-reviewed clinical content and CME for physicians. A longstanding German healthcare trade publication with a similar subscription, CME and association-affiliated model, but serving physicians rather than pharmacists.
• Fachverlag Springer Nature (Springer Healthcare): Global academic and professional publisher with a substantial healthcare news and education portfolio. Wider scope than DAZ but useful comparable for digital-first healthcare subscription and sponsored-content business models.
• Thieme Gruppe: Major German medical publisher producing journals, books, digital content and CME programs for healthcare professionals. Comparable as a German-language medical publisher with subscription, CME and professional-association relationships.

Emerging players

• Pharma-Fokus / Healthcare-Focus Digital Properties: Smaller German healthcare / pharmacy digital news and conference properties. Comparable to DAZ as a niche trade publication monetizing through advertising, events and newsletters, though typically with thinner content cadence.
• DocCheck News: German-language digital health news and community platform serving healthcare professionals (initially physicians). Comparable as a community-driven, ad- and content-supported healthcare trade publication; useful emerging benchmark for digital engagement models.

Others

• DAZ.jobpharm / Jobpharm: Embedded recruitment marketplace for German pharmacy professionals, integrated with DAZ. Not a direct news competitor, but illustrates DAZ's adjacent/vertical monetization through specialist job-board partnerships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/DAZ.online
• LinkedInlinkedin.com/company/deutsche-apotheker-zeitung
• Instagraminstagram.com/deutscheapothekerzeitung/?hl=de

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Deutsche Apotheker Zeitung